nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—Parkinson's disease—Clonazepam—epilepsy syndrome	0.203	0.554	CpDpCtD
Cabergoline—Parkinson's disease—Gabapentin—epilepsy syndrome	0.164	0.446	CpDpCtD
Cabergoline—HTR7—epilepsy syndrome	0.107	0.424	CbGaD
Cabergoline—ADRA2A—epilepsy syndrome	0.0915	0.363	CbGaD
Cabergoline—HTR2A—epilepsy syndrome	0.0537	0.213	CbGaD
Cabergoline—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00817	0.0878	CbGbCtD
Cabergoline—CYP3A4—Felbamate—epilepsy syndrome	0.00759	0.0817	CbGbCtD
Cabergoline—CYP3A4—Trimethadione—epilepsy syndrome	0.00759	0.0817	CbGbCtD
Cabergoline—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00714	0.0768	CbGbCtD
Cabergoline—CYP3A4—Clonazepam—epilepsy syndrome	0.00645	0.0694	CbGbCtD
Cabergoline—CYP3A4—Clobazam—epilepsy syndrome	0.00619	0.0666	CbGbCtD
Cabergoline—CYP3A4—Rufinamide—epilepsy syndrome	0.00526	0.0566	CbGbCtD
Cabergoline—CYP3A4—Carbamazepine—epilepsy syndrome	0.00513	0.0552	CbGbCtD
Cabergoline—CYP3A4—Primidone—epilepsy syndrome	0.00479	0.0515	CbGbCtD
Cabergoline—CYP3A4—Phenytoin—epilepsy syndrome	0.0046	0.0495	CbGbCtD
Cabergoline—HTR1D—meninx—epilepsy syndrome	0.00446	0.0807	CbGeAlD
Cabergoline—CYP3A4—Propofol—epilepsy syndrome	0.00429	0.0461	CbGbCtD
Cabergoline—CYP3A4—Phenobarbital—epilepsy syndrome	0.0041	0.0441	CbGbCtD
Cabergoline—CYP3A4—Acetazolamide—epilepsy syndrome	0.0041	0.0441	CbGbCtD
Cabergoline—CYP3A4—Midazolam—epilepsy syndrome	0.00404	0.0435	CbGbCtD
Cabergoline—CYP3A4—Diazepam—epilepsy syndrome	0.00389	0.0418	CbGbCtD
Cabergoline—CYP3A4—Zonisamide—epilepsy syndrome	0.00379	0.0408	CbGbCtD
Cabergoline—CYP3A4—Valproic Acid—epilepsy syndrome	0.00306	0.033	CbGbCtD
Cabergoline—CYP3A4—Topiramate—epilepsy syndrome	0.00276	0.0297	CbGbCtD
Cabergoline—HTR2A—phrenic nerve—epilepsy syndrome	0.0024	0.0434	CbGeAlD
Cabergoline—DRD3—telencephalic ventricle—epilepsy syndrome	0.00182	0.0329	CbGeAlD
Cabergoline—HTR7—locus ceruleus—epilepsy syndrome	0.00172	0.0311	CbGeAlD
Cabergoline—HTR7—vagus nerve—epilepsy syndrome	0.00132	0.0238	CbGeAlD
Cabergoline—DRD1—telencephalic ventricle—epilepsy syndrome	0.0013	0.0236	CbGeAlD
Cabergoline—HTR2A—locus ceruleus—epilepsy syndrome	0.00107	0.0194	CbGeAlD
Cabergoline—DRD5—ganglion—epilepsy syndrome	0.00106	0.0192	CbGeAlD
Cabergoline—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00106	0.0191	CbGeAlD
Cabergoline—HTR1D—telencephalic ventricle—epilepsy syndrome	0.00102	0.0185	CbGeAlD
Cabergoline—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00101	0.0183	CbGeAlD
Cabergoline—HTR7—pons—epilepsy syndrome	0.00099	0.0179	CbGeAlD
Cabergoline—HTR7—autonomic nervous system—epilepsy syndrome	0.000913	0.0165	CbGeAlD
Cabergoline—HTR2A—cerebellar cortex—epilepsy syndrome	0.000873	0.0158	CbGeAlD
Cabergoline—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000852	0.0154	CbGeAlD
Cabergoline—HTR2A—vagus nerve—epilepsy syndrome	0.00082	0.0148	CbGeAlD
Cabergoline—HTR7—telencephalic ventricle—epilepsy syndrome	0.000815	0.0147	CbGeAlD
Cabergoline—DRD1—ganglion—epilepsy syndrome	0.000811	0.0147	CbGeAlD
Cabergoline—DRD2—telencephalic ventricle—epilepsy syndrome	0.00077	0.0139	CbGeAlD
Cabergoline—HTR1B—ganglion—epilepsy syndrome	0.000658	0.0119	CbGeAlD
Cabergoline—HTR1D—ganglion—epilepsy syndrome	0.000637	0.0115	CbGeAlD
Cabergoline—HTR2C—ganglion—epilepsy syndrome	0.00063	0.0114	CbGeAlD
Cabergoline—HTR2A—pons—epilepsy syndrome	0.000617	0.0112	CbGeAlD
Cabergoline—HTR2A—autonomic nervous system—epilepsy syndrome	0.000569	0.0103	CbGeAlD
Cabergoline—HTR1A—ganglion—epilepsy syndrome	0.000531	0.00959	CbGeAlD
Cabergoline—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000508	0.00919	CbGeAlD
Cabergoline—HTR7—ganglion—epilepsy syndrome	0.000507	0.00917	CbGeAlD
Cabergoline—DRD2—ganglion—epilepsy syndrome	0.000479	0.00867	CbGeAlD
Cabergoline—DRD5—forebrain—epilepsy syndrome	0.000446	0.00806	CbGeAlD
Cabergoline—Pergolide—ADRA2A—epilepsy syndrome	0.00041	0.252	CrCbGaD
Cabergoline—DRD5—telencephalon—epilepsy syndrome	0.00041	0.00741	CbGeAlD
Cabergoline—HTR1A—hindbrain—epilepsy syndrome	0.000402	0.00728	CbGeAlD
Cabergoline—HTR7—hindbrain—epilepsy syndrome	0.000385	0.00695	CbGeAlD
Cabergoline—ADRA1A—hindbrain—epilepsy syndrome	0.000371	0.00671	CbGeAlD
Cabergoline—DRD2—hindbrain—epilepsy syndrome	0.000364	0.00657	CbGeAlD
Cabergoline—ADRA1D—forebrain—epilepsy syndrome	0.000357	0.00646	CbGeAlD
Cabergoline—Lisuride—ADRA2A—epilepsy syndrome	0.000356	0.219	CrCbGaD
Cabergoline—DRD1—brainstem—epilepsy syndrome	0.000353	0.00638	CbGeAlD
Cabergoline—DRD1—forebrain—epilepsy syndrome	0.00034	0.00616	CbGeAlD
Cabergoline—ADRA1D—telencephalon—epilepsy syndrome	0.000329	0.00594	CbGeAlD
Cabergoline—HTR2A—ganglion—epilepsy syndrome	0.000316	0.00572	CbGeAlD
Cabergoline—DRD1—telencephalon—epilepsy syndrome	0.000313	0.00566	CbGeAlD
Cabergoline—HTR1B—brainstem—epilepsy syndrome	0.000286	0.00517	CbGeAlD
Cabergoline—DRD4—brain—epilepsy syndrome	0.000281	0.00507	CbGeAlD
Cabergoline—HTR1D—brainstem—epilepsy syndrome	0.000277	0.005	CbGeAlD
Cabergoline—HTR1B—forebrain—epilepsy syndrome	0.000276	0.00499	CbGeAlD
Cabergoline—HTR2C—brainstem—epilepsy syndrome	0.000274	0.00495	CbGeAlD
Cabergoline—DRD3—head—epilepsy syndrome	0.000272	0.00492	CbGeAlD
Cabergoline—HTR1D—forebrain—epilepsy syndrome	0.000267	0.00483	CbGeAlD
Cabergoline—HTR2C—forebrain—epilepsy syndrome	0.000264	0.00478	CbGeAlD
Cabergoline—ADRB1—forebrain—epilepsy syndrome	0.00026	0.00469	CbGeAlD
Cabergoline—DRD3—nervous system—epilepsy syndrome	0.000258	0.00467	CbGeAlD
Cabergoline—DRD5—head—epilepsy syndrome	0.000255	0.00461	CbGeAlD
Cabergoline—HTR1B—telencephalon—epilepsy syndrome	0.000254	0.00459	CbGeAlD
Cabergoline—DRD3—central nervous system—epilepsy syndrome	0.000248	0.00449	CbGeAlD
Cabergoline—HTR2B—forebrain—epilepsy syndrome	0.000248	0.00449	CbGeAlD
Cabergoline—HTR1D—telencephalon—epilepsy syndrome	0.000246	0.00444	CbGeAlD
Cabergoline—HTR2C—telencephalon—epilepsy syndrome	0.000243	0.0044	CbGeAlD
Cabergoline—DRD5—nervous system—epilepsy syndrome	0.000242	0.00437	CbGeAlD
Cabergoline—Pergolide—HTR2A—epilepsy syndrome	0.000241	0.148	CrCbGaD
Cabergoline—HTR2A—hindbrain—epilepsy syndrome	0.00024	0.00434	CbGeAlD
Cabergoline—ADRB1—telencephalon—epilepsy syndrome	0.000239	0.00431	CbGeAlD
Cabergoline—DRD5—central nervous system—epilepsy syndrome	0.000233	0.00421	CbGeAlD
Cabergoline—HTR1A—brainstem—epilepsy syndrome	0.000231	0.00417	CbGeAlD
Cabergoline—HTR2B—telencephalon—epilepsy syndrome	0.000228	0.00413	CbGeAlD
Cabergoline—DRD1—midbrain—epilepsy syndrome	0.000225	0.00406	CbGeAlD
Cabergoline—HTR1A—forebrain—epilepsy syndrome	0.000223	0.00403	CbGeAlD
Cabergoline—HTR7—brainstem—epilepsy syndrome	0.00022	0.00399	CbGeAlD
Cabergoline—Pergolide—CYP2D6—epilepsy syndrome	0.00022	0.135	CrCbGaD
Cabergoline—HTR7—forebrain—epilepsy syndrome	0.000213	0.00385	CbGeAlD
Cabergoline—ADRA1A—brainstem—epilepsy syndrome	0.000213	0.00384	CbGeAlD
Cabergoline—ADRA1B—head—epilepsy syndrome	0.000209	0.00378	CbGeAlD
Cabergoline—Lisuride—HTR2A—epilepsy syndrome	0.000209	0.128	CrCbGaD
Cabergoline—DRD2—brainstem—epilepsy syndrome	0.000208	0.00377	CbGeAlD
Cabergoline—ADRA1A—forebrain—epilepsy syndrome	0.000205	0.00371	CbGeAlD
Cabergoline—HTR1A—telencephalon—epilepsy syndrome	0.000205	0.0037	CbGeAlD
Cabergoline—ADRA1D—head—epilepsy syndrome	0.000205	0.0037	CbGeAlD
Cabergoline—DRD2—forebrain—epilepsy syndrome	0.000201	0.00364	CbGeAlD
Cabergoline—ADRA1B—nervous system—epilepsy syndrome	0.000198	0.00359	CbGeAlD
Cabergoline—DRD3—brain—epilepsy syndrome	0.000197	0.00357	CbGeAlD
Cabergoline—HTR7—telencephalon—epilepsy syndrome	0.000196	0.00354	CbGeAlD
Cabergoline—DRD1—head—epilepsy syndrome	0.000195	0.00352	CbGeAlD
Cabergoline—ADRA1D—nervous system—epilepsy syndrome	0.000194	0.00351	CbGeAlD
Cabergoline—HTR2C—medulla oblongata—epilepsy syndrome	0.000191	0.00345	CbGeAlD
Cabergoline—Lisuride—CYP2D6—epilepsy syndrome	0.000191	0.117	CrCbGaD
Cabergoline—ADRA1B—central nervous system—epilepsy syndrome	0.000191	0.00345	CbGeAlD
Cabergoline—ADRA1A—telencephalon—epilepsy syndrome	0.000189	0.00341	CbGeAlD
Cabergoline—ADRA1D—central nervous system—epilepsy syndrome	0.000187	0.00338	CbGeAlD
Cabergoline—DRD2—telencephalon—epilepsy syndrome	0.000185	0.00334	CbGeAlD
Cabergoline—DRD5—brain—epilepsy syndrome	0.000185	0.00334	CbGeAlD
Cabergoline—DRD1—nervous system—epilepsy syndrome	0.000185	0.00334	CbGeAlD
Cabergoline—HTR1B—midbrain—epilepsy syndrome	0.000182	0.00329	CbGeAlD
Cabergoline—ADRA2C—telencephalon—epilepsy syndrome	0.00018	0.00325	CbGeAlD
Cabergoline—DRD1—central nervous system—epilepsy syndrome	0.000178	0.00322	CbGeAlD
Cabergoline—HTR1B—spinal cord—epilepsy syndrome	0.000178	0.00321	CbGeAlD
Cabergoline—HTR1D—midbrain—epilepsy syndrome	0.000176	0.00319	CbGeAlD
Cabergoline—HTR2C—midbrain—epilepsy syndrome	0.000175	0.00316	CbGeAlD
Cabergoline—HTR2C—spinal cord—epilepsy syndrome	0.00017	0.00308	CbGeAlD
Cabergoline—HTR1B—head—epilepsy syndrome	0.000158	0.00286	CbGeAlD
Cabergoline—ADRA2A—forebrain—epilepsy syndrome	0.000156	0.00282	CbGeAlD
Cabergoline—HTR7—medulla oblongata—epilepsy syndrome	0.000154	0.00278	CbGeAlD
Cabergoline—HTR1D—head—epilepsy syndrome	0.000153	0.00277	CbGeAlD
Cabergoline—ADRA1B—brain—epilepsy syndrome	0.000152	0.00274	CbGeAlD
Cabergoline—HTR2C—head—epilepsy syndrome	0.000151	0.00274	CbGeAlD
Cabergoline—HTR1B—nervous system—epilepsy syndrome	0.00015	0.00271	CbGeAlD
Cabergoline—ADRB1—head—epilepsy syndrome	0.000149	0.00269	CbGeAlD
Cabergoline—ADRA1D—brain—epilepsy syndrome	0.000148	0.00268	CbGeAlD
Cabergoline—HTR1A—midbrain—epilepsy syndrome	0.000147	0.00266	CbGeAlD
Cabergoline—HTR1D—nervous system—epilepsy syndrome	0.000145	0.00262	CbGeAlD
Cabergoline—HTR1B—central nervous system—epilepsy syndrome	0.000144	0.00261	CbGeAlD
Cabergoline—HTR2C—nervous system—epilepsy syndrome	0.000144	0.0026	CbGeAlD
Cabergoline—ADRA2A—telencephalon—epilepsy syndrome	0.000143	0.00259	CbGeAlD
Cabergoline—HTR1A—spinal cord—epilepsy syndrome	0.000143	0.00259	CbGeAlD
Cabergoline—HTR2B—head—epilepsy syndrome	0.000142	0.00257	CbGeAlD
Cabergoline—ADRA2C—medulla oblongata—epilepsy syndrome	0.000141	0.00255	CbGeAlD
Cabergoline—DRD1—brain—epilepsy syndrome	0.000141	0.00255	CbGeAlD
Cabergoline—ADRB1—nervous system—epilepsy syndrome	0.000141	0.00255	CbGeAlD
Cabergoline—HTR7—midbrain—epilepsy syndrome	0.00014	0.00254	CbGeAlD
Cabergoline—HTR1D—central nervous system—epilepsy syndrome	0.00014	0.00252	CbGeAlD
Cabergoline—HTR2C—central nervous system—epilepsy syndrome	0.000138	0.0025	CbGeAlD
Cabergoline—HTR2A—brainstem—epilepsy syndrome	0.000137	0.00249	CbGeAlD
Cabergoline—HTR7—spinal cord—epilepsy syndrome	0.000137	0.00248	CbGeAlD
Cabergoline—ADRB1—central nervous system—epilepsy syndrome	0.000136	0.00245	CbGeAlD
Cabergoline—HTR2B—nervous system—epilepsy syndrome	0.000135	0.00244	CbGeAlD
Cabergoline—DRD2—midbrain—epilepsy syndrome	0.000133	0.0024	CbGeAlD
Cabergoline—HTR2A—forebrain—epilepsy syndrome	0.000133	0.0024	CbGeAlD
Cabergoline—HTR2B—central nervous system—epilepsy syndrome	0.00013	0.00235	CbGeAlD
Cabergoline—ADRA2C—midbrain—epilepsy syndrome	0.000129	0.00233	CbGeAlD
Cabergoline—HTR1A—head—epilepsy syndrome	0.000127	0.0023	CbGeAlD
Cabergoline—ADRA2C—spinal cord—epilepsy syndrome	0.000126	0.00228	CbGeAlD
Cabergoline—HTR2A—telencephalon—epilepsy syndrome	0.000122	0.00221	CbGeAlD
Cabergoline—HTR7—head—epilepsy syndrome	0.000122	0.0022	CbGeAlD
Cabergoline—HTR1A—nervous system—epilepsy syndrome	0.000121	0.00219	CbGeAlD
Cabergoline—ADRA1A—head—epilepsy syndrome	0.000117	0.00212	CbGeAlD
Cabergoline—HTR1A—central nervous system—epilepsy syndrome	0.000116	0.0021	CbGeAlD
Cabergoline—HTR7—nervous system—epilepsy syndrome	0.000115	0.00209	CbGeAlD
Cabergoline—DRD2—head—epilepsy syndrome	0.000115	0.00208	CbGeAlD
Cabergoline—HTR1B—brain—epilepsy syndrome	0.000114	0.00207	CbGeAlD
Cabergoline—HTR1A—cerebellum—epilepsy syndrome	0.000114	0.00206	CbGeAlD
Cabergoline—ADRA2A—medulla oblongata—epilepsy syndrome	0.000113	0.00204	CbGeAlD
Cabergoline—ADRA2C—head—epilepsy syndrome	0.000112	0.00202	CbGeAlD
Cabergoline—ADRA1A—nervous system—epilepsy syndrome	0.000111	0.00201	CbGeAlD
Cabergoline—HTR7—central nervous system—epilepsy syndrome	0.000111	0.00201	CbGeAlD
Cabergoline—HTR1D—brain—epilepsy syndrome	0.000111	0.002	CbGeAlD
Cabergoline—HTR2C—brain—epilepsy syndrome	0.00011	0.00198	CbGeAlD
Cabergoline—DRD2—nervous system—epilepsy syndrome	0.000109	0.00197	CbGeAlD
Cabergoline—HTR7—cerebellum—epilepsy syndrome	0.000109	0.00197	CbGeAlD
Cabergoline—ADRB1—brain—epilepsy syndrome	0.000108	0.00195	CbGeAlD
Cabergoline—ADRA1A—central nervous system—epilepsy syndrome	0.000107	0.00194	CbGeAlD
Cabergoline—ADRA2C—nervous system—epilepsy syndrome	0.000106	0.00192	CbGeAlD
Cabergoline—DRD2—central nervous system—epilepsy syndrome	0.000105	0.0019	CbGeAlD
Cabergoline—ADRA1A—cerebellum—epilepsy syndrome	0.000105	0.0019	CbGeAlD
Cabergoline—HTR2B—brain—epilepsy syndrome	0.000103	0.00186	CbGeAlD
Cabergoline—ADRA2A—midbrain—epilepsy syndrome	0.000103	0.00186	CbGeAlD
Cabergoline—DRD2—cerebellum—epilepsy syndrome	0.000103	0.00186	CbGeAlD
Cabergoline—ADRA2C—central nervous system—epilepsy syndrome	0.000102	0.00185	CbGeAlD
Cabergoline—ADRA2A—spinal cord—epilepsy syndrome	0.000101	0.00182	CbGeAlD
Cabergoline—ADRA2C—cerebellum—epilepsy syndrome	9.99e-05	0.00181	CbGeAlD
Cabergoline—HTR2A—medulla oblongata—epilepsy syndrome	9.58e-05	0.00173	CbGeAlD
Cabergoline—HTR1A—brain—epilepsy syndrome	9.24e-05	0.00167	CbGeAlD
Cabergoline—ADRA2A—head—epilepsy syndrome	8.93e-05	0.00162	CbGeAlD
Cabergoline—HTR7—brain—epilepsy syndrome	8.83e-05	0.0016	CbGeAlD
Cabergoline—HTR2A—midbrain—epilepsy syndrome	8.76e-05	0.00158	CbGeAlD
Cabergoline—HTR2A—spinal cord—epilepsy syndrome	8.55e-05	0.00155	CbGeAlD
Cabergoline—ADRA1A—brain—epilepsy syndrome	8.51e-05	0.00154	CbGeAlD
Cabergoline—ADRA2A—nervous system—epilepsy syndrome	8.47e-05	0.00153	CbGeAlD
Cabergoline—DRD2—brain—epilepsy syndrome	8.35e-05	0.00151	CbGeAlD
Cabergoline—ADRA2A—central nervous system—epilepsy syndrome	8.15e-05	0.00147	CbGeAlD
Cabergoline—ADRA2C—brain—epilepsy syndrome	8.11e-05	0.00147	CbGeAlD
Cabergoline—ADRA2A—cerebellum—epilepsy syndrome	7.97e-05	0.00144	CbGeAlD
Cabergoline—HTR2A—head—epilepsy syndrome	7.6e-05	0.00137	CbGeAlD
Cabergoline—HTR2A—nervous system—epilepsy syndrome	7.2e-05	0.0013	CbGeAlD
Cabergoline—HTR2A—central nervous system—epilepsy syndrome	6.93e-05	0.00125	CbGeAlD
Cabergoline—HTR2A—cerebellum—epilepsy syndrome	6.78e-05	0.00123	CbGeAlD
Cabergoline—CYP3A4—nervous system—epilepsy syndrome	6.67e-05	0.00121	CbGeAlD
Cabergoline—ADRA2A—brain—epilepsy syndrome	6.47e-05	0.00117	CbGeAlD
Cabergoline—CYP3A4—central nervous system—epilepsy syndrome	6.42e-05	0.00116	CbGeAlD
Cabergoline—HTR2A—brain—epilepsy syndrome	5.5e-05	0.000995	CbGeAlD
Cabergoline—Dry mouth—Valproic Acid—epilepsy syndrome	4.47e-05	0.000329	CcSEcCtD
Cabergoline—Headache—Levetiracetam—epilepsy syndrome	4.46e-05	0.000329	CcSEcCtD
Cabergoline—Hypersensitivity—Clonazepam—epilepsy syndrome	4.44e-05	0.000327	CcSEcCtD
Cabergoline—Dizziness—Vigabatrin—epilepsy syndrome	4.43e-05	0.000326	CcSEcCtD
Cabergoline—Confusional state—Valproic Acid—epilepsy syndrome	4.42e-05	0.000326	CcSEcCtD
Cabergoline—Pruritus—Zonisamide—epilepsy syndrome	4.42e-05	0.000326	CcSEcCtD
Cabergoline—Hypersensitivity—Phenytoin—epilepsy syndrome	4.41e-05	0.000325	CcSEcCtD
Cabergoline—Flatulence—Gabapentin—epilepsy syndrome	4.39e-05	0.000323	CcSEcCtD
Cabergoline—Oedema—Valproic Acid—epilepsy syndrome	4.38e-05	0.000323	CcSEcCtD
Cabergoline—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	4.38e-05	0.000323	CcSEcCtD
Cabergoline—Malaise—Pregabalin—epilepsy syndrome	4.38e-05	0.000323	CcSEcCtD
Cabergoline—Nausea—Propofol—epilepsy syndrome	4.38e-05	0.000322	CcSEcCtD
Cabergoline—Tension—Gabapentin—epilepsy syndrome	4.37e-05	0.000322	CcSEcCtD
Cabergoline—Vomiting—Fosphenytoin—epilepsy syndrome	4.37e-05	0.000322	CcSEcCtD
Cabergoline—Diarrhoea—Felbamate—epilepsy syndrome	4.37e-05	0.000322	CcSEcCtD
Cabergoline—Vertigo—Pregabalin—epilepsy syndrome	4.36e-05	0.000321	CcSEcCtD
Cabergoline—Abdominal pain—Lamotrigine—epilepsy syndrome	4.36e-05	0.000321	CcSEcCtD
Cabergoline—Dizziness—Diazepam—epilepsy syndrome	4.36e-05	0.000321	CcSEcCtD
Cabergoline—Syncope—Pregabalin—epilepsy syndrome	4.36e-05	0.000321	CcSEcCtD
Cabergoline—Rash—Fosphenytoin—epilepsy syndrome	4.33e-05	0.000319	CcSEcCtD
Cabergoline—Dermatitis—Fosphenytoin—epilepsy syndrome	4.33e-05	0.000319	CcSEcCtD
Cabergoline—Nervousness—Gabapentin—epilepsy syndrome	4.33e-05	0.000319	CcSEcCtD
Cabergoline—Asthenia—Clonazepam—epilepsy syndrome	4.32e-05	0.000318	CcSEcCtD
Cabergoline—Rhinitis—Topiramate—epilepsy syndrome	4.32e-05	0.000318	CcSEcCtD
Cabergoline—Back pain—Gabapentin—epilepsy syndrome	4.31e-05	0.000317	CcSEcCtD
Cabergoline—Headache—Fosphenytoin—epilepsy syndrome	4.31e-05	0.000317	CcSEcCtD
Cabergoline—Palpitations—Pregabalin—epilepsy syndrome	4.29e-05	0.000316	CcSEcCtD
Cabergoline—Asthenia—Phenytoin—epilepsy syndrome	4.29e-05	0.000316	CcSEcCtD
Cabergoline—Nausea—Midazolam—epilepsy syndrome	4.28e-05	0.000315	CcSEcCtD
Cabergoline—Hallucination—Topiramate—epilepsy syndrome	4.28e-05	0.000315	CcSEcCtD
Cabergoline—Muscle spasms—Gabapentin—epilepsy syndrome	4.28e-05	0.000315	CcSEcCtD
Cabergoline—Diarrhoea—Zonisamide—epilepsy syndrome	4.28e-05	0.000315	CcSEcCtD
Cabergoline—Loss of consciousness—Pregabalin—epilepsy syndrome	4.27e-05	0.000314	CcSEcCtD
Cabergoline—Asthenia—Oxcarbazepine—epilepsy syndrome	4.27e-05	0.000314	CcSEcCtD
Cabergoline—Pruritus—Clonazepam—epilepsy syndrome	4.26e-05	0.000314	CcSEcCtD
Cabergoline—Vomiting—Vigabatrin—epilepsy syndrome	4.26e-05	0.000314	CcSEcCtD
Cabergoline—Oedema peripheral—Topiramate—epilepsy syndrome	4.24e-05	0.000312	CcSEcCtD
Cabergoline—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.24e-05	0.000312	CcSEcCtD
Cabergoline—Pruritus—Phenytoin—epilepsy syndrome	4.23e-05	0.000312	CcSEcCtD
Cabergoline—Nausea—Levetiracetam—epilepsy syndrome	4.23e-05	0.000312	CcSEcCtD
Cabergoline—Rash—Vigabatrin—epilepsy syndrome	4.22e-05	0.000311	CcSEcCtD
Cabergoline—Dizziness—Felbamate—epilepsy syndrome	4.22e-05	0.000311	CcSEcCtD
Cabergoline—Dermatitis—Vigabatrin—epilepsy syndrome	4.22e-05	0.000311	CcSEcCtD
Cabergoline—Pruritus—Oxcarbazepine—epilepsy syndrome	4.21e-05	0.00031	CcSEcCtD
Cabergoline—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.21e-05	0.00031	CcSEcCtD
Cabergoline—Headache—Vigabatrin—epilepsy syndrome	4.2e-05	0.000309	CcSEcCtD
Cabergoline—Hypertension—Pregabalin—epilepsy syndrome	4.19e-05	0.000309	CcSEcCtD
Cabergoline—Vomiting—Diazepam—epilepsy syndrome	4.19e-05	0.000309	CcSEcCtD
Cabergoline—Anorexia—Valproic Acid—epilepsy syndrome	4.18e-05	0.000308	CcSEcCtD
Cabergoline—Rash—Diazepam—epilepsy syndrome	4.16e-05	0.000306	CcSEcCtD
Cabergoline—Dermatitis—Diazepam—epilepsy syndrome	4.15e-05	0.000306	CcSEcCtD
Cabergoline—Visual impairment—Topiramate—epilepsy syndrome	4.15e-05	0.000306	CcSEcCtD
Cabergoline—Arthralgia—Pregabalin—epilepsy syndrome	4.14e-05	0.000305	CcSEcCtD
Cabergoline—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.13e-05	0.000304	CcSEcCtD
Cabergoline—Dizziness—Zonisamide—epilepsy syndrome	4.13e-05	0.000304	CcSEcCtD
Cabergoline—Headache—Diazepam—epilepsy syndrome	4.13e-05	0.000304	CcSEcCtD
Cabergoline—Anxiety—Pregabalin—epilepsy syndrome	4.12e-05	0.000304	CcSEcCtD
Cabergoline—Diarrhoea—Clonazepam—epilepsy syndrome	4.12e-05	0.000303	CcSEcCtD
Cabergoline—Hypotension—Valproic Acid—epilepsy syndrome	4.1e-05	0.000302	CcSEcCtD
Cabergoline—Asthenia—Carbamazepine—epilepsy syndrome	4.1e-05	0.000302	CcSEcCtD
Cabergoline—Diarrhoea—Phenytoin—epilepsy syndrome	4.09e-05	0.000301	CcSEcCtD
Cabergoline—Discomfort—Pregabalin—epilepsy syndrome	4.09e-05	0.000301	CcSEcCtD
Cabergoline—Nausea—Fosphenytoin—epilepsy syndrome	4.08e-05	0.000301	CcSEcCtD
Cabergoline—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.07e-05	0.0003	CcSEcCtD
Cabergoline—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.07e-05	0.000299	CcSEcCtD
Cabergoline—Vomiting—Felbamate—epilepsy syndrome	4.06e-05	0.000299	CcSEcCtD
Cabergoline—Dry mouth—Pregabalin—epilepsy syndrome	4.04e-05	0.000298	CcSEcCtD
Cabergoline—Pruritus—Carbamazepine—epilepsy syndrome	4.04e-05	0.000298	CcSEcCtD
Cabergoline—Rash—Felbamate—epilepsy syndrome	4.02e-05	0.000296	CcSEcCtD
Cabergoline—Dermatitis—Felbamate—epilepsy syndrome	4.02e-05	0.000296	CcSEcCtD
Cabergoline—Malaise—Gabapentin—epilepsy syndrome	4.02e-05	0.000296	CcSEcCtD
Cabergoline—Vertigo—Gabapentin—epilepsy syndrome	4e-05	0.000295	CcSEcCtD
Cabergoline—Headache—Felbamate—epilepsy syndrome	4e-05	0.000295	CcSEcCtD
Cabergoline—Confusional state—Pregabalin—epilepsy syndrome	4e-05	0.000294	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4e-05	0.000294	CcSEcCtD
Cabergoline—Cardiac disorder—Topiramate—epilepsy syndrome	4e-05	0.000294	CcSEcCtD
Cabergoline—Syncope—Gabapentin—epilepsy syndrome	3.99e-05	0.000294	CcSEcCtD
Cabergoline—Dizziness—Clonazepam—epilepsy syndrome	3.98e-05	0.000293	CcSEcCtD
Cabergoline—Nausea—Vigabatrin—epilepsy syndrome	3.98e-05	0.000293	CcSEcCtD
Cabergoline—Vomiting—Zonisamide—epilepsy syndrome	3.97e-05	0.000293	CcSEcCtD
Cabergoline—Insomnia—Valproic Acid—epilepsy syndrome	3.97e-05	0.000292	CcSEcCtD
Cabergoline—Oedema—Pregabalin—epilepsy syndrome	3.96e-05	0.000292	CcSEcCtD
Cabergoline—Asthenia—Lamotrigine—epilepsy syndrome	3.96e-05	0.000292	CcSEcCtD
Cabergoline—Dizziness—Phenytoin—epilepsy syndrome	3.96e-05	0.000291	CcSEcCtD
Cabergoline—Rash—Zonisamide—epilepsy syndrome	3.94e-05	0.00029	CcSEcCtD
Cabergoline—Paraesthesia—Valproic Acid—epilepsy syndrome	3.94e-05	0.00029	CcSEcCtD
Cabergoline—Palpitations—Gabapentin—epilepsy syndrome	3.94e-05	0.00029	CcSEcCtD
Cabergoline—Dermatitis—Zonisamide—epilepsy syndrome	3.94e-05	0.00029	CcSEcCtD
Cabergoline—Dizziness—Oxcarbazepine—epilepsy syndrome	3.93e-05	0.00029	CcSEcCtD
Cabergoline—Nausea—Diazepam—epilepsy syndrome	3.92e-05	0.000289	CcSEcCtD
Cabergoline—Loss of consciousness—Gabapentin—epilepsy syndrome	3.91e-05	0.000288	CcSEcCtD
Cabergoline—Headache—Zonisamide—epilepsy syndrome	3.91e-05	0.000288	CcSEcCtD
Cabergoline—Dyspnoea—Valproic Acid—epilepsy syndrome	3.91e-05	0.000288	CcSEcCtD
Cabergoline—Diarrhoea—Carbamazepine—epilepsy syndrome	3.91e-05	0.000288	CcSEcCtD
Cabergoline—Pruritus—Lamotrigine—epilepsy syndrome	3.9e-05	0.000288	CcSEcCtD
Cabergoline—Shock—Pregabalin—epilepsy syndrome	3.9e-05	0.000287	CcSEcCtD
Cabergoline—Somnolence—Valproic Acid—epilepsy syndrome	3.9e-05	0.000287	CcSEcCtD
Cabergoline—Dyspepsia—Valproic Acid—epilepsy syndrome	3.86e-05	0.000284	CcSEcCtD
Cabergoline—Hypertension—Gabapentin—epilepsy syndrome	3.85e-05	0.000283	CcSEcCtD
Cabergoline—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.83e-05	0.000282	CcSEcCtD
Cabergoline—Vomiting—Clonazepam—epilepsy syndrome	3.83e-05	0.000282	CcSEcCtD
Cabergoline—Decreased appetite—Valproic Acid—epilepsy syndrome	3.81e-05	0.000281	CcSEcCtD
Cabergoline—Alopecia—Topiramate—epilepsy syndrome	3.8e-05	0.00028	CcSEcCtD
Cabergoline—Vomiting—Phenytoin—epilepsy syndrome	3.8e-05	0.00028	CcSEcCtD
Cabergoline—Rash—Clonazepam—epilepsy syndrome	3.8e-05	0.00028	CcSEcCtD
Cabergoline—Dermatitis—Clonazepam—epilepsy syndrome	3.79e-05	0.000279	CcSEcCtD
Cabergoline—Arthralgia—Gabapentin—epilepsy syndrome	3.79e-05	0.000279	CcSEcCtD
Cabergoline—Nausea—Felbamate—epilepsy syndrome	3.79e-05	0.000279	CcSEcCtD
Cabergoline—Vomiting—Oxcarbazepine—epilepsy syndrome	3.78e-05	0.000279	CcSEcCtD
Cabergoline—Fatigue—Valproic Acid—epilepsy syndrome	3.78e-05	0.000278	CcSEcCtD
Cabergoline—Anxiety—Gabapentin—epilepsy syndrome	3.78e-05	0.000278	CcSEcCtD
Cabergoline—Anorexia—Pregabalin—epilepsy syndrome	3.78e-05	0.000278	CcSEcCtD
Cabergoline—Dizziness—Carbamazepine—epilepsy syndrome	3.78e-05	0.000278	CcSEcCtD
Cabergoline—Diarrhoea—Lamotrigine—epilepsy syndrome	3.78e-05	0.000278	CcSEcCtD
Cabergoline—Headache—Clonazepam—epilepsy syndrome	3.77e-05	0.000278	CcSEcCtD
Cabergoline—Rash—Phenytoin—epilepsy syndrome	3.77e-05	0.000278	CcSEcCtD
Cabergoline—Dermatitis—Phenytoin—epilepsy syndrome	3.77e-05	0.000278	CcSEcCtD
Cabergoline—Rash—Oxcarbazepine—epilepsy syndrome	3.75e-05	0.000276	CcSEcCtD
Cabergoline—Pain—Valproic Acid—epilepsy syndrome	3.75e-05	0.000276	CcSEcCtD
Cabergoline—Constipation—Valproic Acid—epilepsy syndrome	3.75e-05	0.000276	CcSEcCtD
Cabergoline—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.75e-05	0.000276	CcSEcCtD
Cabergoline—Headache—Phenytoin—epilepsy syndrome	3.75e-05	0.000276	CcSEcCtD
Cabergoline—Discomfort—Gabapentin—epilepsy syndrome	3.75e-05	0.000276	CcSEcCtD
Cabergoline—Headache—Oxcarbazepine—epilepsy syndrome	3.73e-05	0.000275	CcSEcCtD
Cabergoline—Nausea—Zonisamide—epilepsy syndrome	3.71e-05	0.000273	CcSEcCtD
Cabergoline—Dry mouth—Gabapentin—epilepsy syndrome	3.71e-05	0.000273	CcSEcCtD
Cabergoline—Hypotension—Pregabalin—epilepsy syndrome	3.7e-05	0.000273	CcSEcCtD
Cabergoline—Flatulence—Topiramate—epilepsy syndrome	3.69e-05	0.000272	CcSEcCtD
Cabergoline—Tension—Topiramate—epilepsy syndrome	3.68e-05	0.000271	CcSEcCtD
Cabergoline—Confusional state—Gabapentin—epilepsy syndrome	3.67e-05	0.00027	CcSEcCtD
Cabergoline—Dizziness—Lamotrigine—epilepsy syndrome	3.65e-05	0.000269	CcSEcCtD
Cabergoline—Nervousness—Topiramate—epilepsy syndrome	3.64e-05	0.000268	CcSEcCtD
Cabergoline—Oedema—Gabapentin—epilepsy syndrome	3.64e-05	0.000268	CcSEcCtD
Cabergoline—Vomiting—Carbamazepine—epilepsy syndrome	3.63e-05	0.000267	CcSEcCtD
Cabergoline—Back pain—Topiramate—epilepsy syndrome	3.62e-05	0.000267	CcSEcCtD
Cabergoline—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.61e-05	0.000266	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.61e-05	0.000266	CcSEcCtD
Cabergoline—Muscle spasms—Topiramate—epilepsy syndrome	3.6e-05	0.000265	CcSEcCtD
Cabergoline—Rash—Carbamazepine—epilepsy syndrome	3.6e-05	0.000265	CcSEcCtD
Cabergoline—Dermatitis—Carbamazepine—epilepsy syndrome	3.6e-05	0.000265	CcSEcCtD
Cabergoline—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.59e-05	0.000264	CcSEcCtD
Cabergoline—Insomnia—Pregabalin—epilepsy syndrome	3.59e-05	0.000264	CcSEcCtD
Cabergoline—Nausea—Clonazepam—epilepsy syndrome	3.58e-05	0.000263	CcSEcCtD
Cabergoline—Headache—Carbamazepine—epilepsy syndrome	3.58e-05	0.000263	CcSEcCtD
Cabergoline—Shock—Gabapentin—epilepsy syndrome	3.58e-05	0.000263	CcSEcCtD
Cabergoline—Paraesthesia—Pregabalin—epilepsy syndrome	3.56e-05	0.000262	CcSEcCtD
Cabergoline—Nausea—Phenytoin—epilepsy syndrome	3.55e-05	0.000262	CcSEcCtD
Cabergoline—Dyspnoea—Pregabalin—epilepsy syndrome	3.53e-05	0.00026	CcSEcCtD
Cabergoline—Nausea—Oxcarbazepine—epilepsy syndrome	3.53e-05	0.00026	CcSEcCtD
Cabergoline—Somnolence—Pregabalin—epilepsy syndrome	3.52e-05	0.00026	CcSEcCtD
Cabergoline—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.51e-05	0.000259	CcSEcCtD
Cabergoline—Vomiting—Lamotrigine—epilepsy syndrome	3.51e-05	0.000258	CcSEcCtD
Cabergoline—Rash—Lamotrigine—epilepsy syndrome	3.48e-05	0.000256	CcSEcCtD
Cabergoline—Ill-defined disorder—Topiramate—epilepsy syndrome	3.48e-05	0.000256	CcSEcCtD
Cabergoline—Dermatitis—Lamotrigine—epilepsy syndrome	3.48e-05	0.000256	CcSEcCtD
Cabergoline—Abdominal pain—Valproic Acid—epilepsy syndrome	3.47e-05	0.000255	CcSEcCtD
Cabergoline—Anorexia—Gabapentin—epilepsy syndrome	3.47e-05	0.000255	CcSEcCtD
Cabergoline—Headache—Lamotrigine—epilepsy syndrome	3.46e-05	0.000255	CcSEcCtD
Cabergoline—Decreased appetite—Pregabalin—epilepsy syndrome	3.45e-05	0.000254	CcSEcCtD
Cabergoline—Fatigue—Pregabalin—epilepsy syndrome	3.42e-05	0.000252	CcSEcCtD
Cabergoline—Hypotension—Gabapentin—epilepsy syndrome	3.4e-05	0.00025	CcSEcCtD
Cabergoline—Nausea—Carbamazepine—epilepsy syndrome	3.39e-05	0.00025	CcSEcCtD
Cabergoline—Constipation—Pregabalin—epilepsy syndrome	3.39e-05	0.00025	CcSEcCtD
Cabergoline—Pain—Pregabalin—epilepsy syndrome	3.39e-05	0.00025	CcSEcCtD
Cabergoline—Malaise—Topiramate—epilepsy syndrome	3.38e-05	0.000249	CcSEcCtD
Cabergoline—Vertigo—Topiramate—epilepsy syndrome	3.37e-05	0.000248	CcSEcCtD
Cabergoline—Syncope—Topiramate—epilepsy syndrome	3.36e-05	0.000248	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.31e-05	0.000244	CcSEcCtD
Cabergoline—Palpitations—Topiramate—epilepsy syndrome	3.31e-05	0.000244	CcSEcCtD
Cabergoline—Loss of consciousness—Topiramate—epilepsy syndrome	3.29e-05	0.000243	CcSEcCtD
Cabergoline—Insomnia—Gabapentin—epilepsy syndrome	3.29e-05	0.000242	CcSEcCtD
Cabergoline—Nausea—Lamotrigine—epilepsy syndrome	3.28e-05	0.000241	CcSEcCtD
Cabergoline—Feeling abnormal—Pregabalin—epilepsy syndrome	3.27e-05	0.000241	CcSEcCtD
Cabergoline—Paraesthesia—Gabapentin—epilepsy syndrome	3.26e-05	0.00024	CcSEcCtD
Cabergoline—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.24e-05	0.000239	CcSEcCtD
Cabergoline—Dyspnoea—Gabapentin—epilepsy syndrome	3.24e-05	0.000239	CcSEcCtD
Cabergoline—Hypertension—Topiramate—epilepsy syndrome	3.24e-05	0.000238	CcSEcCtD
Cabergoline—Somnolence—Gabapentin—epilepsy syndrome	3.23e-05	0.000238	CcSEcCtD
Cabergoline—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.23e-05	0.000238	CcSEcCtD
Cabergoline—Dyspepsia—Gabapentin—epilepsy syndrome	3.2e-05	0.000236	CcSEcCtD
Cabergoline—Arthralgia—Topiramate—epilepsy syndrome	3.19e-05	0.000235	CcSEcCtD
Cabergoline—Anxiety—Topiramate—epilepsy syndrome	3.18e-05	0.000234	CcSEcCtD
Cabergoline—Decreased appetite—Gabapentin—epilepsy syndrome	3.16e-05	0.000233	CcSEcCtD
Cabergoline—Discomfort—Topiramate—epilepsy syndrome	3.15e-05	0.000232	CcSEcCtD
Cabergoline—Asthenia—Valproic Acid—epilepsy syndrome	3.15e-05	0.000232	CcSEcCtD
Cabergoline—Fatigue—Gabapentin—epilepsy syndrome	3.13e-05	0.000231	CcSEcCtD
Cabergoline—Abdominal pain—Pregabalin—epilepsy syndrome	3.13e-05	0.000231	CcSEcCtD
Cabergoline—Dry mouth—Topiramate—epilepsy syndrome	3.12e-05	0.00023	CcSEcCtD
Cabergoline—Pain—Gabapentin—epilepsy syndrome	3.11e-05	0.000229	CcSEcCtD
Cabergoline—Constipation—Gabapentin—epilepsy syndrome	3.11e-05	0.000229	CcSEcCtD
Cabergoline—Pruritus—Valproic Acid—epilepsy syndrome	3.1e-05	0.000228	CcSEcCtD
Cabergoline—Confusional state—Topiramate—epilepsy syndrome	3.08e-05	0.000227	CcSEcCtD
Cabergoline—Oedema—Topiramate—epilepsy syndrome	3.06e-05	0.000225	CcSEcCtD
Cabergoline—Shock—Topiramate—epilepsy syndrome	3.01e-05	0.000222	CcSEcCtD
Cabergoline—Diarrhoea—Valproic Acid—epilepsy syndrome	3e-05	0.000221	CcSEcCtD
Cabergoline—Feeling abnormal—Gabapentin—epilepsy syndrome	3e-05	0.000221	CcSEcCtD
Cabergoline—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.97e-05	0.000219	CcSEcCtD
Cabergoline—Hyperhidrosis—Topiramate—epilepsy syndrome	2.96e-05	0.000218	CcSEcCtD
Cabergoline—Hypersensitivity—Pregabalin—epilepsy syndrome	2.92e-05	0.000215	CcSEcCtD
Cabergoline—Anorexia—Topiramate—epilepsy syndrome	2.92e-05	0.000215	CcSEcCtD
Cabergoline—Dizziness—Valproic Acid—epilepsy syndrome	2.9e-05	0.000214	CcSEcCtD
Cabergoline—Abdominal pain—Gabapentin—epilepsy syndrome	2.87e-05	0.000212	CcSEcCtD
Cabergoline—Hypotension—Topiramate—epilepsy syndrome	2.86e-05	0.00021	CcSEcCtD
Cabergoline—Asthenia—Pregabalin—epilepsy syndrome	2.84e-05	0.000209	CcSEcCtD
Cabergoline—Pruritus—Pregabalin—epilepsy syndrome	2.8e-05	0.000207	CcSEcCtD
Cabergoline—Vomiting—Valproic Acid—epilepsy syndrome	2.79e-05	0.000205	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.79e-05	0.000205	CcSEcCtD
Cabergoline—Insomnia—Topiramate—epilepsy syndrome	2.77e-05	0.000204	CcSEcCtD
Cabergoline—Rash—Valproic Acid—epilepsy syndrome	2.76e-05	0.000204	CcSEcCtD
Cabergoline—Dermatitis—Valproic Acid—epilepsy syndrome	2.76e-05	0.000203	CcSEcCtD
Cabergoline—Headache—Valproic Acid—epilepsy syndrome	2.75e-05	0.000202	CcSEcCtD
Cabergoline—Paraesthesia—Topiramate—epilepsy syndrome	2.75e-05	0.000202	CcSEcCtD
Cabergoline—Dyspnoea—Topiramate—epilepsy syndrome	2.73e-05	0.000201	CcSEcCtD
Cabergoline—Somnolence—Topiramate—epilepsy syndrome	2.72e-05	0.0002	CcSEcCtD
Cabergoline—Diarrhoea—Pregabalin—epilepsy syndrome	2.71e-05	0.0002	CcSEcCtD
Cabergoline—Dyspepsia—Topiramate—epilepsy syndrome	2.69e-05	0.000198	CcSEcCtD
Cabergoline—Hypersensitivity—Gabapentin—epilepsy syndrome	2.68e-05	0.000197	CcSEcCtD
Cabergoline—Decreased appetite—Topiramate—epilepsy syndrome	2.66e-05	0.000196	CcSEcCtD
Cabergoline—Fatigue—Topiramate—epilepsy syndrome	2.64e-05	0.000194	CcSEcCtD
Cabergoline—Dizziness—Pregabalin—epilepsy syndrome	2.62e-05	0.000193	CcSEcCtD
Cabergoline—Pain—Topiramate—epilepsy syndrome	2.62e-05	0.000193	CcSEcCtD
Cabergoline—Constipation—Topiramate—epilepsy syndrome	2.62e-05	0.000193	CcSEcCtD
Cabergoline—Asthenia—Gabapentin—epilepsy syndrome	2.61e-05	0.000192	CcSEcCtD
Cabergoline—Nausea—Valproic Acid—epilepsy syndrome	2.6e-05	0.000192	CcSEcCtD
Cabergoline—Pruritus—Gabapentin—epilepsy syndrome	2.57e-05	0.000189	CcSEcCtD
Cabergoline—Vomiting—Pregabalin—epilepsy syndrome	2.52e-05	0.000186	CcSEcCtD
Cabergoline—Feeling abnormal—Topiramate—epilepsy syndrome	2.52e-05	0.000186	CcSEcCtD
Cabergoline—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.5e-05	0.000184	CcSEcCtD
Cabergoline—Rash—Pregabalin—epilepsy syndrome	2.5e-05	0.000184	CcSEcCtD
Cabergoline—Dermatitis—Pregabalin—epilepsy syndrome	2.5e-05	0.000184	CcSEcCtD
Cabergoline—Diarrhoea—Gabapentin—epilepsy syndrome	2.49e-05	0.000183	CcSEcCtD
Cabergoline—Headache—Pregabalin—epilepsy syndrome	2.48e-05	0.000183	CcSEcCtD
Cabergoline—Abdominal pain—Topiramate—epilepsy syndrome	2.42e-05	0.000178	CcSEcCtD
Cabergoline—Dizziness—Gabapentin—epilepsy syndrome	2.4e-05	0.000177	CcSEcCtD
Cabergoline—Nausea—Pregabalin—epilepsy syndrome	2.35e-05	0.000173	CcSEcCtD
Cabergoline—Vomiting—Gabapentin—epilepsy syndrome	2.31e-05	0.00017	CcSEcCtD
Cabergoline—Rash—Gabapentin—epilepsy syndrome	2.29e-05	0.000169	CcSEcCtD
Cabergoline—Dermatitis—Gabapentin—epilepsy syndrome	2.29e-05	0.000169	CcSEcCtD
Cabergoline—Headache—Gabapentin—epilepsy syndrome	2.28e-05	0.000168	CcSEcCtD
Cabergoline—Hypersensitivity—Topiramate—epilepsy syndrome	2.25e-05	0.000166	CcSEcCtD
Cabergoline—Asthenia—Topiramate—epilepsy syndrome	2.19e-05	0.000162	CcSEcCtD
Cabergoline—Pruritus—Topiramate—epilepsy syndrome	2.16e-05	0.000159	CcSEcCtD
Cabergoline—Nausea—Gabapentin—epilepsy syndrome	2.16e-05	0.000159	CcSEcCtD
Cabergoline—Diarrhoea—Topiramate—epilepsy syndrome	2.09e-05	0.000154	CcSEcCtD
Cabergoline—Dizziness—Topiramate—epilepsy syndrome	2.02e-05	0.000149	CcSEcCtD
Cabergoline—Vomiting—Topiramate—epilepsy syndrome	1.94e-05	0.000143	CcSEcCtD
Cabergoline—Rash—Topiramate—epilepsy syndrome	1.93e-05	0.000142	CcSEcCtD
Cabergoline—Dermatitis—Topiramate—epilepsy syndrome	1.93e-05	0.000142	CcSEcCtD
Cabergoline—Headache—Topiramate—epilepsy syndrome	1.92e-05	0.000141	CcSEcCtD
Cabergoline—Nausea—Topiramate—epilepsy syndrome	1.82e-05	0.000134	CcSEcCtD
Cabergoline—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	1.1e-06	1.15e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	1.1e-06	1.15e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—CASP3—epilepsy syndrome	1.1e-06	1.14e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	1.09e-06	1.14e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	1.09e-06	1.14e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	1.09e-06	1.14e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	1.08e-06	1.13e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	1.08e-06	1.13e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	1.08e-06	1.13e-05	CbGpPWpGaD
Cabergoline—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.08e-06	1.12e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.07e-06	1.12e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	1.07e-06	1.11e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	1.07e-06	1.11e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—JUN—epilepsy syndrome	1.06e-06	1.11e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	1.06e-06	1.11e-05	CbGpPWpGaD
Cabergoline—DRD4—GPCR downstream signaling—AKT1—epilepsy syndrome	1.06e-06	1.11e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	1.06e-06	1.1e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	1.06e-06	1.1e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	1.06e-06	1.1e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	1.05e-06	1.1e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—CASP3—epilepsy syndrome	1.05e-06	1.1e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—RELA—epilepsy syndrome	1.05e-06	1.09e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	1.04e-06	1.09e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.04e-06	1.09e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	1.04e-06	1.08e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.04e-06	1.08e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—MMP9—epilepsy syndrome	1.03e-06	1.08e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	1.03e-06	1.08e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—RELA—epilepsy syndrome	1.03e-06	1.08e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	1.03e-06	1.08e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—POMC—epilepsy syndrome	1.03e-06	1.08e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	1.03e-06	1.07e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	1.03e-06	1.07e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.03e-06	1.07e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	1.02e-06	1.07e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	1.02e-06	1.07e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	1.02e-06	1.07e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	1.02e-06	1.06e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—JUN—epilepsy syndrome	1.02e-06	1.06e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.02e-06	1.06e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.01e-06	1.06e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	1.01e-06	1.06e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	1.01e-06	1.06e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	1.01e-06	1.06e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	1.01e-06	1.06e-05	CbGpPWpGaD
Cabergoline—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.01e-06	1.06e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	1.01e-06	1.05e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	1e-06	1.05e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—AKT1—epilepsy syndrome	1e-06	1.05e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	1e-06	1.05e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	1e-06	1.05e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	9.99e-07	1.04e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	9.97e-07	1.04e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	9.93e-07	1.04e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	9.91e-07	1.04e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—MMP9—epilepsy syndrome	9.91e-07	1.04e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	9.83e-07	1.03e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	9.76e-07	1.02e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	9.72e-07	1.02e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	9.69e-07	1.01e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	9.64e-07	1.01e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—POMC—epilepsy syndrome	9.62e-07	1.01e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—AKT1—epilepsy syndrome	9.61e-07	1e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—SRC—epilepsy syndrome	9.54e-07	9.97e-06	CbGpPWpGaD
Cabergoline—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	9.53e-07	9.95e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	9.48e-07	9.91e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	9.47e-07	9.9e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	9.46e-07	9.88e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	9.46e-07	9.88e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	9.44e-07	9.86e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	9.42e-07	9.84e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	9.42e-07	9.84e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	9.41e-07	9.83e-06	CbGpPWpGaD
Cabergoline—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	9.4e-07	9.82e-06	CbGpPWpGaD
Cabergoline—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	9.4e-07	9.82e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—ALB—epilepsy syndrome	9.39e-07	9.82e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	9.38e-07	9.8e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	9.32e-07	9.74e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	9.31e-07	9.73e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	9.31e-07	9.73e-06	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	9.29e-07	9.71e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	9.28e-07	9.7e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	9.27e-07	9.69e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	9.27e-07	9.68e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	9.23e-07	9.65e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	9.23e-07	9.65e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	9.23e-07	9.64e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	9.2e-07	9.62e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	9.17e-07	9.59e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—JUN—epilepsy syndrome	9.17e-07	9.58e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	9.14e-07	9.55e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—SRC—epilepsy syndrome	9.13e-07	9.54e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	9.07e-07	9.48e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	9.05e-07	9.45e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—JUN—epilepsy syndrome	9.05e-07	9.45e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	9.04e-07	9.45e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	9.02e-07	9.43e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	9e-07	9.4e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	8.96e-07	9.36e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	8.95e-07	9.35e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	8.92e-07	9.32e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—VEGFA—epilepsy syndrome	8.9e-07	9.3e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	8.82e-07	9.22e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	8.8e-07	9.2e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	8.8e-07	9.2e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	8.78e-07	9.17e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	8.72e-07	9.11e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	8.71e-07	9.1e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	8.65e-07	9.04e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	8.62e-07	9e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	8.57e-07	8.95e-06	CbGpPWpGaD
Cabergoline—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	8.56e-07	8.95e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	8.54e-07	8.92e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	8.54e-07	8.92e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	8.54e-07	8.92e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	8.53e-07	8.91e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	8.51e-07	8.89e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—BCHE—epilepsy syndrome	8.49e-07	8.88e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	8.49e-07	8.87e-06	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	8.49e-07	8.87e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	8.48e-07	8.87e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	8.43e-07	8.81e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	8.41e-07	8.79e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	8.4e-07	8.78e-06	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	8.38e-07	8.75e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	8.37e-07	8.75e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	8.3e-07	8.67e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	8.24e-07	8.61e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—SRC—epilepsy syndrome	8.22e-07	8.59e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	8.22e-07	8.59e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	8.2e-07	8.57e-06	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	8.19e-07	8.56e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	8.17e-07	8.53e-06	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	8.15e-07	8.52e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	8.12e-07	8.48e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—SRC—epilepsy syndrome	8.11e-07	8.48e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	8.11e-07	8.48e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	8.1e-07	8.47e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	8.07e-07	8.44e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	8.06e-07	8.42e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	8.02e-07	8.38e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	8.01e-07	8.37e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	8.01e-07	8.37e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—TH—epilepsy syndrome	7.99e-07	8.34e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	7.94e-07	8.3e-06	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	7.93e-07	8.28e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	7.9e-07	8.26e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	7.9e-07	8.26e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—RELA—epilepsy syndrome	7.9e-07	8.26e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	7.88e-07	8.24e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	7.85e-07	8.21e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	7.84e-07	8.2e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	7.84e-07	8.2e-06	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	7.8e-07	8.15e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	7.78e-07	8.13e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	7.77e-07	8.12e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	7.75e-07	8.1e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	7.73e-07	8.08e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	7.71e-07	8.05e-06	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—AKT1—epilepsy syndrome	7.69e-07	8.04e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	7.67e-07	8.01e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	7.63e-07	7.97e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	7.63e-07	7.97e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	7.62e-07	7.97e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	7.62e-07	7.96e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	7.61e-07	7.95e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	7.61e-07	7.95e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	7.51e-07	7.84e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	7.46e-07	7.8e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	7.44e-07	7.77e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	7.42e-07	7.76e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	7.4e-07	7.73e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	7.39e-07	7.72e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	7.32e-07	7.65e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	7.3e-07	7.63e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	7.23e-07	7.56e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	7.2e-07	7.52e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	7.2e-07	7.52e-06	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	7.19e-07	7.52e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	7.13e-07	7.46e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	7.13e-07	7.45e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	7.08e-07	7.4e-06	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	7.08e-07	7.39e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	7.07e-07	7.39e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	7.07e-07	7.39e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	7.04e-07	7.36e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	7.03e-07	7.35e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	7.01e-07	7.33e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	6.94e-07	7.25e-06	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	6.93e-07	7.24e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—JUN—epilepsy syndrome	6.92e-07	7.23e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	6.89e-07	7.2e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	6.87e-07	7.17e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	6.85e-07	7.16e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	6.84e-07	7.15e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	6.81e-07	7.12e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	6.73e-07	7.04e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	6.73e-07	7.04e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	6.67e-07	6.97e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	6.67e-07	6.96e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	6.66e-07	6.96e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	6.63e-07	6.92e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CAT—epilepsy syndrome	6.58e-07	6.87e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	6.56e-07	6.85e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	6.53e-07	6.82e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	6.49e-07	6.78e-06	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	6.44e-07	6.73e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	6.43e-07	6.72e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	6.4e-07	6.68e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	6.38e-07	6.67e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	6.29e-07	6.58e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—SRC—epilepsy syndrome	6.21e-07	6.49e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	6.2e-07	6.47e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	6.11e-07	6.38e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	6.05e-07	6.32e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	6.03e-07	6.3e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	5.98e-07	6.25e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	5.95e-07	6.22e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GPX1—epilepsy syndrome	5.95e-07	6.21e-06	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	5.93e-07	6.2e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	5.89e-07	6.16e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	5.85e-07	6.11e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	5.83e-07	6.09e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	5.77e-07	6.03e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—AKT1—epilepsy syndrome	5.68e-07	5.93e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	5.56e-07	5.81e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	5.42e-07	5.66e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	5.41e-07	5.66e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—AGT—epilepsy syndrome	5.22e-07	5.45e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	5.11e-07	5.34e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOE—epilepsy syndrome	5.11e-07	5.34e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—AKT1—epilepsy syndrome	5.09e-07	5.31e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	5.04e-07	5.27e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	5.04e-07	5.27e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	4.59e-07	4.8e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	4.55e-07	4.76e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	4.49e-07	4.7e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	4.39e-07	4.59e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—POMC—epilepsy syndrome	4.39e-07	4.59e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	4.37e-07	4.57e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	4.25e-07	4.44e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	4.18e-07	4.37e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—AKT1—epilepsy syndrome	4.13e-07	4.32e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ALB—epilepsy syndrome	4e-07	4.18e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	3.86e-07	4.03e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	3.8e-07	3.97e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	3.72e-07	3.88e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.5e-07	3.66e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	3.45e-07	3.61e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.76e-07	1.84e-06	CbGpPWpGaD
